Cadila Healthcare, the pharmaceutical company, today reported a net profit of Rs 118 crore, an increase of 105 per cent for the quarter ended March 31, 2010. It had posted a net profit of Rs 58 crore for the same quarter a year ago.
Net sales for the reporting period was up by 16 per cent at Rs 815 crore as against Rs 702 crore posted in the corresponding quarter a year earlier, according to a statement posted by the Bombay Stock Exchange.
There was a substantial reduction in the financial cost for the company at Rs 16.86 crore for the quarter as compared to Rs 31.09 crore in the same period last year. Its interest payout was down by 64 per cent.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app